Hepatitis B surface antigen (HBsAg) prevalence (%) in Niger
Niger: Hepatitis B surface antigen (HBsAg) prevalence was 3.2% in 2024. ▲ Rising
Latest (2024)
3.2%
Change on year
down 5.9%
World rank
3rd
of 194 countries
All-time high
3.6%
in 2021
All-time low
2.1%
in 2015
Years of data
10
2015–2024
Hepatitis B surface antigen (HBsAg) prevalence in Niger, 2015–2024
Source: World Health Organization, Global Health Observatory.
Analysis
The most recent figure for hepatitis b surface antigen (hbsag) prevalence in Niger is 3.2%, measured in 2024.
That represents a change of down 5.9% on the previous year and up 52.4% over ten years.
Over the whole period, hepatitis b surface antigen (hbsag) prevalence in Niger peaked at 3.6% in 2021 and was at its lowest, 2.1%, in 2015.
Niger ranks 3rd of 194 countries on this measure, in the top 10%.
Hepatitis B surface antigen (HBsAg) prevalence in Niger, year by year
| Year | Value | Change |
|---|---|---|
| 2015 | 2.1% | — |
| 2016 | 2.3% | +9.5% |
| 2017 | 2.6% | +13.0% |
| 2018 | 3.0% | +15.4% |
| 2019 | 3.2% | +6.7% |
| 2020 | 3.5% | +9.4% |
| 2021 | 3.6% | +2.9% |
| 2022 | 3.5% | -2.8% |
| 2023 | 3.4% | -2.9% |
| 2024 | 3.2% | -5.9% |
Niger compared with similar countries
- Niger's 3.2% is above the median for low income countries, which is 0.7%, 4.6× the median. (25 countries reporting)
- Niger's 3.2% is above the median for Sub-Saharan Africa, which is 1.1%, 3.0× the median. (48 countries reporting)
Averages by decade
| Decade | Average | Lowest | Highest | Years |
|---|---|---|---|---|
| 2010s | 2.6% | 2.1% | 3.2% | 5 |
| 2020s | 3.4% | 3.2% | 3.6% | 5 |
Countries ranked near Niger
More health data for Niger
- Un projection of annual infant deaths, annual growth rate -1.58 % change on previous year (2100)
- Heat deaths vs projected death rates, annual growth rate 1.35 % change on previous year (2090)
- Estimated changes in temperature-related death rates compared to projected death rates 887.5 deaths per 1,000 people (2090)
- Number of infants who die before age 1 22,995 deaths (2100)
- Neonatal tetanus - number of reported cases, gaps filled 15 (2025)
- Population ages 00-04, female, annual growth rate 2.54 % change on previous year (2025)
- Population ages 00-04, female, per unit of GDP 0.0001 units per US$ of GDP (2025)
- Population ages 00-04, female, per capita 0.0865 units per person (2025)
- Population ages 00-04, male, annual growth rate 2.53 % change on previous year (2025)
- Population ages 00-04, male, per unit of GDP 0.0001 units per US$ of GDP (2025)
Frequently asked questions
- What is hepatitis b surface antigen (hbsag) prevalence in Niger?
- Hepatitis b surface antigen (hbsag) prevalence in Niger was 3.2% in 2024, according to World Health Organization, Global Health Observatory.
- What is the highest hepatitis b surface antigen (hbsag) prevalence recorded in Niger?
- The highest recorded value was 3.6% in 2021.
- What is the lowest hepatitis b surface antigen (hbsag) prevalence recorded in Niger?
- The lowest recorded value was 2.1% in 2015.
- How does Niger rank for hepatitis b surface antigen (hbsag) prevalence?
- Niger ranks 3rd out of 194 countries with data for 2024.
- Is hepatitis b surface antigen (hbsag) prevalence rising or falling in Niger?
- Over the last ten years it is up 52.4%. The long-run trend across the full record is rising.
- Where does this Niger data come from?
- The figures come from World Health Organization, Global Health Observatory, published as part of Hepatitis B surface antigen (HBsAg) prevalence (%). Statizoid updates them automatically from the source API.
Download this data
CSV · JSON — 10 observations, free to reuse under CC BY-NC-SA 3.0 IGO (WHO).